PT  - JOURNAL ARTICLE
AU  - Lucía Méndez González
AU  - Pedro Castro
AU  - Catia Caneiras
TI  - The impact of Healthcare-Associated Pneumonia in patients admitted in a Northern Portuguese hospital
AID  - 10.1183/13993003.congress-2021.PA1744
DP  - 2021 Sep 05
TA  - European Respiratory Journal
PG  - PA1744
VI  - 58
IP  - suppl 65
4099  - http://erj.ersjournals.com/content/58/suppl_65/PA1744.short
4100  - http://erj.ersjournals.com/content/58/suppl_65/PA1744.full
SO  - Eur Respir J2021 Sep 05; 58
AB  - Introduction: Pneumonia is one of the main causes of hospitalization and mortality.Healthcare-associated pneumonia (HCAP) is the most frequent complication of sanitary care and affect hundreds of millions of patients around the world, although the actual number of patients affected is unknown due the difficulty of reliable data. The studies about HCAP in Portugal are scarce.Objective: To study the impact of HCAP on individuals admitted to hospital by pneumonia.Methods: This is a quantitative descriptive study with retrospective analysis of the clinical processes of hospital admitted individuals with pneumonia diagnostic during 1 year (2018).Results: A total of 2,436 individuals were found. Of this, 735 (30.2%) were HCAP. There were 10 (0.4%) individuals with ventilator-associated pneumonia (VAP) and 193 (7.9%) with hospital-acquired pneumonia. Data showed that 153 (20.8%) HCAP situations resulted in death, which was 41.5% of all pneumonia deaths in hospitalized individuals. In only 59 (2.4%) of the individuals the agents causing pneumonia were isolated. The most frequent pathogens were Gram-negative bacteria Kebsiella pneumoniae (37.3%) and Pseudomonas aeruginosa (13.5%).Discussion: HCAP was one of the main causes of pneumonia hospital admissions and mortality. Moreover, most pneumonias are treated empirically with a low microorganisms isolated. Therefore, it is critical to promote the surveillance of HCAP indicators as hospital quality of care.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA1744.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).